Tavaris Brooks
Family · Milton, FLNPI 1609359868
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.9%), food and beverage and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Medtronic at 37.7% of the total. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 82 payments — averaging $55.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$2K
- Abbott$189
- AstraZeneca$144
- Abiomed$124
- Lexicon Pharmaceuticals, Inc.$122
- plus $764 from 14 others
What the payments were for
- Travel & lodging$2,36852%
- Food & beverage$2,17848%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 11 | $1,721 |
| Boston Scientific | 12 | $1,501 |
| Abbott | 2 | $189 |
| AstraZeneca | 7 | $144 |
| Abiomed | 1 | $124 |
| Lexicon Pharmaceuticals, Inc. | 5 | $122 |
| Novartis | 8 | $121 |
| Amgen | 7 | $104 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $101 |
| Bayer | 4 | $77 |
| Philips North America LLC | 3 | $68 |
| Merck | 4 | $63 |
| Boehringer Ingelheim | 3 | $57 |
| E.r. Squibb & Sons, L.L.C. | 3 | $55 |
| Johnson & Johnson | 2 | $30 |
| Corcept Therapeutics | 1 | $24 |
| AbbVie | 1 | $24 |
| Scpharmaceuticals Inc. | 1 | $17 |
| Pfizer | 1 | $14 |
| Tactile Systems Technology Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,566 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 184 | $204,596 |
| EntrestoSacubitril/Valsartan | 57 | $88,718 |
| MultaqDronedarone Hcl | 14 | $23,040 |
| FarxigaDapagliflozin Propanediol | 15 | $22,164 |
| Metoprolol Succinate | 170 | $1,698 |
| Atorvastatin Calcium | 118 | $1,188 |
| Losartan Potassium | 107 | $1,188 |
| Rosuvastatin Calcium | 43 | $996 |
| Eplerenone | 13 | $928 |
| Carvedilol | 96 | $871 |
| Spironolactone | 91 | $816 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 50 | $633 |
| Amlodipine Besylate | 76 | $540 |
| Metoprolol Tartrate | 81 | $438 |
| Lisinopril | 70 | $414 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $14 | $204,596184 claims |
| NovartisEntresto | $121 | $88,71857 claims |
| AstraZenecaFarxiga | $144 | $22,16415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.
Other family in Milton
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.